Trial Profile
Pharmacokinetic study of Bendamustine as a component combination regimen R-B(O)AD for the Treatment of Primary Central Nervous System Lymphoma (Pcnsl)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2018
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Cytarabine; Dexamethasone; Rituximab; Vincristine
- Indications Lymphoma
- Focus Pharmacokinetics
- 23 Jul 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association.